netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 30 of 67

Older Oldest

Details
LDL Link Added : MHRA Drug Safety Update (Dec 2014): Rituximab: progressive multifocal leukoencephalopathy in a patient : https://www.gov.uk/drug-safety-update/rituximab-progressive-multifocal-leukoencephalopathy-in-a-patient
14/07/2023 13:23:56
(dmcdermott )
LDL Link Added : MHRA Drug Safety Update (Dec 2013): Rituximab: screen for hepatitis B virus before treatment. : https://www.gov.uk/drug-safety-update/rituximab-screen-for-hepatitis-b-virus-before-treatment
06/07/2023 11:36:34
(rpaylor )
LDL Link Added : NICE TA243: Rituximab for the first-line treatment of stage III-IV follicular lymphoma : https://www.nice.org.uk/guidance/ta243
06/07/2023 11:36:02
(rpaylor )
LDL Link Added : NICE TA226: Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma : https://www.nice.org.uk/guidance/ta226
06/07/2023 11:35:35
(rpaylor )
LDL Link Added : NICE TA193: Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia : https://www.nice.org.uk/guidance/ta193
06/07/2023 11:35:14
(rpaylor )
LDL Link Added : NICE TA174: Rituximab for the first-line treatment of chronic lymphocytic leukaemia : https://www.nice.org.uk/guidance/ta174
06/07/2023 11:34:53
(rpaylor )
LDL Link Added : NICE TA137: Rituximab for the treatment of relapsed or refractory stage III or IV follicular non- Hodgkin's lymphoma : https://www.nice.org.uk/guidance/ta137
06/07/2023 11:34:18
(rpaylor )
UPD sitematrix Changed from 0 to
14/02/2023 16:18:13
(DavidS )
UPD FurtherInformation Changed from

NICE have approved rituximab for the following indications:
14/02/2023 16:18:13
(DavidS )
UPD Rituximab NHSE SSC 2440
14/02/2023 16:18:13
(DavidS )
UPD sitematrix Changed from 0 to
14/02/2023 16:02:22
(DavidS )
UPD FurtherInformation Changed from

NICE have approved rituximab for the following indications:
14/02/2023 16:02:22
(DavidS )
UPD Rituximab updated - NHSE SSC2433
14/02/2023 16:02:22
(DavidS )
UPD sitematrix Changed from 0 to
27/07/2022 08:30:08
(LoweryM )
UPD FurtherInformation Changed from

NICE have approved rituximab for the following indications:
27/07/2022 08:30:08
(LoweryM )
UPD Rituximab minor formatting
27/07/2022 08:30:08
(LoweryM )
UPD Published from Draft Mode
27/07/2022 08:29:38
(LoweryM )
UPD sitematrix Changed from 0 to
27/07/2022 08:29:28
(LoweryM )
UPD FurtherInformation Changed from

NICE have approved rituximab for the following indications:
27/07/2022 08:29:28
(LoweryM )
UPD Rituximab approved
27/07/2022 08:29:28
(LoweryM )
UPD sitematrix Changed from 0 to
27/07/2022 08:29:02
(LoweryM )
UPD FurtherInformation Changed from

NICE have approved rituximab for the following indications:
27/07/2022 08:29:02
(LoweryM )
UPD Rituximab approved - minor formatting and age added to newly diagnosed mantle cell NHL
27/07/2022 08:29:02
(LoweryM )
UPD sitematrix Changed from 0 to
14/07/2022 10:08:12
(DavidS )
UPD isDraft Changed from N to Y
14/07/2022 10:08:12
(DavidS )
UPD FurtherInformation Changed from

NICE have approved rituximab for the following indications:
14/07/2022 10:08:12
(DavidS )
UPD Rituximab Updated indications. APC July 2022
14/07/2022 10:08:12
(DavidS )
UPD Rituximab Published from Draft Mode
03/02/2022 12:34:13
(DavidS )
UPD sitematrix Changed from 0 to
03/02/2022 12:25:25
(DavidS )
UPD FurtherInformation Changed from

NICE have approved rituximab for the following indications:
03/02/2022 12:25:25
(DavidS )

 

 
netFormulary